Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease
Author: Usmani, Z.
Carson, K.
Cheng, J.
Esterman, A.
Smith, B.
Citation: Cochrane Database of Systematic Reviews, 2011; 11(8483):1-27
Publisher: Update Software Ltd
Issue Date: 2011
ISSN: 1469-493X
Statement of
Zafar A Usmani, Kristin V Carson, Jien N Cheng, Adrian J Esterman and Brian J Smith
Abstract: Patients with COPD (emphysema and chronic bronchitis) are more likely to have anxiety disorders compared with the general population. These symptoms adversely affect various aspects of daily life. Medications are widely used to treat these symptoms but there is little evidence to support this practice. This systematic review of four studies (total of 40 participants) found insufficient evidence of benefit for any of the three classes of medications included in this review. There is a considerable lack of evidence to address pharmacological interventions for anxiety disorders in patients with COPD. We recommend that new research be conducted to ascertain the best mode of treatment for anxiety within this population. This new research needs to be of good methodological design, investigate an adequate number of patients and have a meaningful length of follow-up.
Keywords: Humans
Pulmonary Disease, Chronic Obstructive
Serotonin Uptake Inhibitors
Anti-Anxiety Agents
Antidepressive Agents, Tricyclic
Anxiety Disorders
Randomized Controlled Trials as Topic
Rights: Copyright © 2011 The Cochrane Collaboration.
DOI: 10.1002/14651858.CD008483.pub2
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.